Evaluation Of The Timing Of Intravitreal Bevacizumab Injection As Adjuvant Therapy To Panretinal Photocoagulation In Patients With Diabetic Macular Edema Secondary To Diabetic Retinopathy

Lignende værker

• Effect of Intravitreal Bevacizumab Injection before Panretinal Photocoagulation on the Prevention of Macular Edema Aggravation in Proliferative Diabetic Retinopathy
  af: Choi, Wungrak, et al.
  Udgivet: (2020)
• Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion
  af: Kartasasmita, Arief S, et al.
  Udgivet: (2016)
• Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy
  af: Zhou, Ai-Yi, et al.
  Udgivet: (2016)
• Effects of an Intravitreal Bevacizumab Injection Combined With Panretinal Photocoagulation on High-Risk Proliferative Diabetic Retinopathy
  af: Shin, Yong Woon, et al.
  Udgivet: (2009)
• Intravitreal bevacizumab injection alone or combined with macular photocoagulation compared to macular photocoagulation as primary treatment of diabetic macular edema
  af: Jovanović Sandra, et al.
  Udgivet: (2015-01-01)